Tofersen Clinical Trials
3 recruitingDrug
Phase 41Phase 21
Showing 1–3 of 3 trials
Recruiting
A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Participants With Superoxide Dismutase 1 (SOD-1) Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis
Biogen125 enrolled1 locationNCT07259980
Recruiting
Phase 2
Tofersen in Non-SOD1 ALS
ALS (Amyotrophic Lateral Sclerosis)
Washington University School of Medicine30 enrolled1 locationNCT07294144
Recruiting
Phase 4
A Study to Learn More About the Long-Term Safety of Tofersen (Qalsody) in Chinese Participants With SOD-1 Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis
Biogen12 enrolled1 locationNCT07223723